{"created":"2023-06-20T15:49:13.397053+00:00","id":3796,"links":{},"metadata":{"_buckets":{"deposit":"836180c5-95fa-4eee-9c62-23cfc0d99dfa"},"_deposit":{"created_by":4,"id":"3796","owners":[4],"pid":{"revision_id":0,"type":"depid","value":"3796"},"status":"published"},"_oai":{"id":"oai:hama-med.repo.nii.ac.jp:00003796","sets":["1:11"]},"author_link":[],"item_3_biblio_info_5":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2020-11","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"6","bibliographicPageEnd":"e522","bibliographicPageStart":"e516","bibliographicVolumeNumber":"21","bibliographic_titles":[{"bibliographic_title":"Clinical Lung Cancer"}]}]},"item_3_publisher_6":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Elsevier"}]},"item_3_relation_26":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"32389505","subitem_relation_type_select":"PMID"}}]},"item_3_relation_28":{"attribute_name":"出版社DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1016/j.cllc.2020.04.005","subitem_relation_type_select":"DOI"}}]},"item_3_rights_7":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"Copyright 2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license?http://creativecommons.org/licenses/by-nc-nd/4.0/"},{"subitem_rights":"\"\"\"This is the accepted manuscript version. The formal published version is available at \"\"\"\"https://doi.org/10.1016/j.cllc.2020.04.005\"\"\"\".\"\"\""}]},"item_3_source_id_19":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1525-7304","subitem_source_identifier_type":"ISSN"}]},"item_3_source_id_20":{"attribute_name":"EISSN","attribute_value_mlt":[{"subitem_source_identifier":"1938-0690","subitem_source_identifier_type":"ISSN"}]},"item_3_version_type_32":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Yoshimura, Katsuhiro"}]},{"creatorNames":[{"creatorName":"Saku, Aiko"}]},{"creatorNames":[{"creatorName":"Karayama, Masato"}]},{"creatorNames":[{"creatorName":"Inui, Naoki"}]},{"creatorNames":[{"creatorName":"Sugimura, Haruhiko"}]},{"creatorNames":[{"creatorName":"Suda, Takafumi"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-12-01"}],"displaytype":"detail","filename":"Clin Lung Cancer-21-e516.pdf","filesize":[{"value":"1.2 MB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"Clin Lung Cancer-21-e516.pdf","url":"https://hama-med.repo.nii.ac.jp/record/3796/files/Clin Lung Cancer-21-e516.pdf"},"version_id":"1a366c91-a016-441d-9920-dc2fc80066c4"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"immune-related adverse event (irAE)","subitem_subject_scheme":"Other"},{"subitem_subject":"colitis","subitem_subject_scheme":"Other"},{"subitem_subject":"leucine-rich a2-glycoprotein (LRG)","subitem_subject_scheme":"Other"},{"subitem_subject":"immune checkpoint inhibitor","subitem_subject_scheme":"Other"},{"subitem_subject":"non-small cell lung cancer","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Leucine-rich α2-glycoprotein as a potential biomarker for immune-related colitis after anti-PD-1 therapy: A report of case series","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Leucine-rich α2-glycoprotein as a potential biomarker for immune-related colitis after anti-PD-1 therapy: A report of case series","subitem_title_language":"en"}]},"item_type_id":"3","owner":"4","path":["11"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2021-12-01"},"publish_date":"2021-12-01","publish_status":"0","recid":"3796","relation_version_is_last":true,"title":["Leucine-rich α2-glycoprotein as a potential biomarker for immune-related colitis after anti-PD-1 therapy: A report of case series"],"weko_creator_id":"4","weko_shared_id":-1},"updated":"2023-08-02T07:42:48.791389+00:00"}